Istituto Rudy Lanza - Catalogo bibliografico delle tesi

Tra le infezioni delle vie urinarie “non complicate”, la cistite (infiammazione della mucosa vescicale) colpisce almeno una volta nella vita il 60% delle donne e avviene comunemente per via ascendente, per migrazione attraverso l’uretra, di batteri per lo più di origine intestinale. I batteri responsabili sono E.coli, S.Saprophyticus e occasionalmente Proteus Mirabilis e Klebsiella spp. I sintomi presenti solo alquanto tipici e comprendo: pollachiuria, disuria, stranguria, dolore soprapubico, tenesmo vescicale e possibile sangue nelle urine. Come metodi profilattici alternativi fitoterapici, recenti ricerche hanno messo in luce alcune importanti proprietà di Vaccinium macrocarpon in quanto le proantocianidine prevengono l’adesione delle fimbrie di tipo P dei ceppi uropatogeni di E. coli alla mucosa vescicale.

Il principio attivo dell’Uva ursina, l’arbutina, viene idrolizzato a livello intestinale con liberazione di idrochinone che viene eliminato dalle vie urinarie: è proprio qui che svolge la sua azione disinfettante. È da evitare la concomitante assunzione di sostanze che acidificano le urine, pena la perdita delle proprietà antibatteriche. Ciò avviene anche in presenza della berberina nell’Idraste. Il sistema immunitario svolge un ruolo chiave: l’inulina dell’Echinacea angustifolia ed Echinacea purpurea, attiva la via alternativa del complemento e aumenta la produzione di sostanze chimiche immuni che attivano i macrofagi. La vitamina C, oltre a possedere caratteristiche antivirali e antibatteriche, svolge l’effetto di rafforzamento della resistenza dell’ospite.

Il trattamento deve iniziare dall’identificazione delle cause principali del sorgere della cistite, oltre che dall’assunzione di probiotici, tra cui il Lactobacillus acidophilus e il Bifidobacterium bifido. Nel trattamento della cistite bisogna evitare tutti gli zuccheri semplici, i carboidrati raffinati, i succhi di frutta non diluiti e gli allergeni alimentari. Si dovrebbe introdurre almeno 2 litri di liquidi, di cui almeno la metà dovrebbe essere costituita da acqua, e fibre alimentari di cibi integrali come frutta e verdura. È anche consigliato evitare bevande gassate, caffè e alcol.

Bibliografia:

• Agence Francaise de Securite Sanitarie des Aliments - Uscita N° 2004-SA-0214 e Uscite collegate N° 2003-SA-0056 e N° 2003-SA-0352; 20(5): 285-93.
• Ahuia S et al. Loss of fimbrial adhesion with the addition of Vaccinum Macrocarpon to the growth medium of P-fimbriated E. coli - J Of Urology 1998; 159: 559-62.
• AIFA, Ministero della Salute, Roastbif 2007.
• Amdekar S, et al. Probiotic therapy: immunomodulating approach toward urinary tract infection. Curr Microbiol. 2011; 63:484-90.
• Amin A.H. Subbaiah T.V. Abbasi K.M. Berberine sulfate. Antimicrobial activity, biomassa, and mode of action. Can J Microbiol 1969; 15: 1067-1076.
• Apicella LL, Sobota AE. Increased risk of urinary tract infection associated with the use of calcium supplements. Urol Res. 1990;18(3):213-7.
• Avom L., Monane M. et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271: 751-754.
• Avorn J - Reduction of bacteriuria and pyuria after ingestion of cranberry juice - JAMA 1994; 271 (10): 751-4.
• Avoßrn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271(10):751-754.
• Bailey CJ., K. J. Mynett, T. Page. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol. 1994;112(2):671-675.
• Barefoot S.F., Klaenhammer T.R. Detection and activity of lacticin B, a bacterio cin produced by Lactobacillus acidophilus. Appl Environ Microbiol 1983; 45: 1808-1815.
• Bauer R., Wagner R. Echinacea species as potential immunostimulatory drugs. Econ Med Plant Res 1991; 5: 253-321.
• Blatherwick NR,, Long ML. Studies on urinary acidity. Yhe increased acidity produced by eating prunes and cranberries. J Biol Chem 1923 ;57:815-818.
• Bodel PT. et al.: Cranberry juice and the antibacterialaction of hippuric acid. J Lab Clin Med 1959; 54:881-888.
• Bomser J. Madhavi DL., Singletary K, et al. in vitro anticancer activity of fruit extract from vaccinium species. Planta Med 1996;62:212-6.
• Braunig B. et al. Echinacea purpurea radix for strengthening the immune response in flu-like infections. J Z Phytother 1992; 13:7-13.
• Carlsson S, Weitzberg E, Wiklund P, Lundberg JO. Intravesical nitric oxide delivery for prevention of catheter-associated urinary tract infections. Antimicrob Agents Chemother. 2005; 49:2352-5.
• Chaitow L, Trenev N: Probiotic. Avery publishing Group 1990.
• Clements M.L., Levine M.M., Ristaino P.A. Exogenous lactobacilli fed to man. Their fate and ability to prevent diarrea disease. Prog Food Nutr Sci 1983; 7: 29-37.
• Committee on Safety of Medicines. Possibile interaction between warfarin and cranberry juice. Curr Probl Pharmacovig 2003; 29:8. Committee on Safety of Medicines. Interaction between warfarin and cranberry juice: new advice. Curr Probl Pharmacovig 2004; 30:10.
• CP Siegers et al,. “Metabolism of arbutin from Uvae Ursi-extracts in humans”. Pharm Pharmacol Lett 7 (1997) 2/3: 90-92.
• Dahiya R. S., Speck M. L. Hidrogen peroxide formation by lactobacilli and its effect on Staphylococcus aureus. J Dairy Sci 1968; 51: 1568.
• Dardenne M., Pleau M., Nabarra B. et al. Contribution of zinc and other metal to the bionical activity of the serum thymic factor. Proc Natl Acad Sci 1982; 79: 5370-5373.
• Delzell JE, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000; 61 (3): 713-721.
• Denman SJ, Burton JR. Fluid intake and urinary tract infection in the elderly. JAMA. 1992;267(16):2245-2249).
• Di Martino et al - Reduction of E. coli adherence to uroepithelial bladder cells after consuption of cranberry juice: a double blind randomized placebo-controlled cross-over trial - World J Urol 2006; 24: 21-27.
• Duke JA., “Handbook of medicinal herbs.” Boca Raton: CRC, 1985.
• Erhard M. et al. Effect of echinacea, acontium, lachesis, and apis extracts, and their combinations on phagocytosis of human granulocytes. Phytother Res 1994; 8: 14-77.
• ESCOP monographs on the medicinal uses of plant drugs. Fascicule 5. Devon, European Scientific Cooperative on Phytotherapy, 1997.
• Ferro-Luzzi A, Cialfa E, Leclercq C & Toti E. The Mediterranean diet revisited. Focus on fruit and vegetables. Int. J. Food Sci. Nutr. 1994; 45:291-300.
• Foxman B, Frerichs RR. Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health. 1985 Nov;75(11):1314-7.
• Foxman B, Chi JW. Health behavior and urinary tract infection in college-aged women. J Clin Epidemiol. 1990;43(4):329-37.
• Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(1A):5S-13S.
• Frohne V. Untersuchungen zur frage der harndesifizierenden wirkungen von barentraubenblatt-extracten. Planta Medica 1970; 18: 1-25.
• Fuchs PC, Barry AL, Brown SD. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods. J Antimicrob Chemother 1999;43(1):137-140., Li Pira G, Pruzzo C, Schito GC. Monuril and modification of pathogenicity traits in resistant microorganisms. Eur Urol 1987;13(1):92-97.
• Gayla J. Kirschmann e John D. Kirschmann 1992.
• Gibson G.R., Beatty E.R., Wang X. Selective simulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 975-982.
• Ginter E., Optimum intake of vitamin C for the human organism. Nutr Health 1982; 1: 66-77.
• Goodfriend R - Reduction of bacteriuria and pyuria using cranberry juice - JAMA 1994; 272: 588.
• Griffiths J, Murty M, Pilon K.Suspected warfarin-cranberry juice interaction. CARN 2004; 14:2. Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis 2004; 13:25-6.
• Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999;17(6):415-420.
• Habash MB, Van der Mei HC, Busscher HJ, Reid G. The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber. Can J Microbiol 1999;45:691-694.
• Harrison’s Principles of Internal Medicine 14th Edition MacGraw Hill, 1998.
• Havsteen B. Flavonoids, a classo f natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141-1148.
• Hentges D.J. (ed). Human intestinal microflora. In: Health and disease. New York, NY: Academic Press. 1983.
• Hiadon B., Toxicity of berberine sulfate. Acta Pol Pharm 1975; 32: 113-120.
• Hooton TM, Hillier S, Johnson C, et al. Escherichia coli bacteriuria and contraceptive method. JAMA 1991;265(1):64 69.
• Hooton TM. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551-581.
• Howell AB - A-type cranberry proanthociandins and uropathogenic bacterial anti-adhesion activity - Phytochemistry 2005; 66: 2281-91.
• Howell AB et al - Inhibition of the adherence of P-fimbriated E.Coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cramberries - N. Engl. J. Med 1998; 339: 10856.
• Howell AB, Foxman B. Cranberry Juice and Adhesion of Antibiotic-Resistant Uropathogens JAMA / volume:287 (page: 3082) June 19, 2002.
• Italian Journal Of Internal Medicine, 2003.
• Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections.Cochrane Database Syst Rev. 2001;(3):CD001321.
• Jones W.E. Nutrition/spirulina and mucopolysaccharides. Equine Vet Data 1991; 12: 431-432.
• Kalhoff H. The effect of dietary factors on the risk of developing urinary tract infection. Pediatr Nephrol. 2004 Nov;19(11):1303.
• Kamazawa Y., Itagaki A., Fukumoto M. et al. Activation of peritoneal macrophages by berberine alkaloids in teams of inductions of cytostatic activity. Int J Irnmunopharmacol 1984; 6: 587-592.
• Klaenhammer, T.R. Probiotics and prebiotics. In Food microbiology, funfamentals and frontiers 2nd ed. ASM Press. 2001; 797-811.
• Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322:1571-1573.
• Kontiokari T. Dietary factors protecting women from urinary tract infection. American Journal of Clinical Nutrition 2003; 77: 600-604.
• Kontiokari T. Reply to the letter from H. Kalhoff. Pediatr Nephrol. 2004; 19:1304.
• Larsson B., Jonasson A., Fianu S. Prophylactic effect of UVA-E in women with recurrent cystitis: A preliminary report. Curr Ther Res 1993; 53: 441-443.
• Lee, 2000
• Leung A. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. New York, NY: John Wiley. 1980: p 316-317.
• Liu Y - Role of cranberry juice on molecularscalesurface characteristics and adhesion behaviour of Escherichia coli - Biotechnology and Bioengineering 2006; 93: 297-305.
• Majahan V.M., Sharma A., Rattan A. Antimycotic activity of berberine sulphate. An alkaloid from an Indian medicinal herb. Sabouraudia 1982; 20: 79-81.
• Matsuda H., Nakamura S., Tanaka T., Kubo M. Pharmacological studies on leaf of Arctostaphylos uva-ursi (L.) Spreng. III. Combined effect of arbutin and indomethacin on immuno-inflammation. Yakugaku Zasshi 1991; 111: 256-258.
• Matsuda H., Higashino M., Nakai Y. et al. Studies of cutical drugs from natural sources. IV. Inhibitory effects ofArctostaphylos plants on melanin biosynthesis. Biol Pharm Bull 1996; 19: 153-156.
• Matsuda H., Nakamura S., Tanaka T., Kubo M. Pharmacological studies on leaf of Arctostaphylos uva-ursi (L.) Spreng. V. Effect of water extract from Arctostaphylos uva-ursi (bearberry) on the antiallergic and antininflammatory activities on dexamethasone ointment. Yakugaku Zasshi 1994; 112: 673-677.
• Matsuo K, Kobayashi M, Takuno Y, Kuwajima H, Ito H, Yoshida T. Anti-tyrosinase activity constituents of Arctostaphylos uva-ursi. Journal of the Oharmaceutical Society of Japan 1997; 117: 1028-32.
• Mechart D. et al. Immunomodulation with Echinacea. A systematic review of controller clinical trials. Phytomed 1994; 1: 245-254.
• Merck Index, 10th edn. Rahway, NJ: Merk. 1983: p 112-113, 699.
• Millar LK, Cox SM. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997;11(1):13-26.
• Minoli L. Infezioni urinarie. Approccio integrato per gruppi di rischio. Edizioni Scientifiche PPG, 2001.
• Mitchell W. Naturopathic applications of the botanical remedies. Seattle, WA. 1983: p 8.
• National Center for Health Statistics, November 1999.
• Nazarko L - Infection control. The Therapeutic uses of cranberry juice - Nursing Standard 1995; 9: 33-5.
• Neyestani TR, Khalaji N, Gharavi A. Selective microbiologic effects of tea extract on certain antibiotics against Escherichia coli in vitro. J Altern Complement Med. 2007;13(10):1119-24.
• Nicolle LE, Friesen D, Harding GK, et al. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992: impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 1996;22(6):1051-1056.
• Ochoa-Brust GJ, Fernández AR, Villanueva-Ruiz GJ. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007; 86 (7): 783-7.
• Ofek., 1996.
• Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183:485-491.
• Panrham M.J. Benefit-risk assessment of squeezed sap of the Echinacea purpurea for long-term oral immunostimulation. Phytomed 1996; 3: 95-102.
• Perdigon G, Alvarez S, Pesce de Ruiz Holgado A - Immunocoaudiuvant activityof oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections; J Dairy Res, 1991.
• Perugini F. - Il sistema immunitario associato alle mucose (MALT) e la Medicina Biologica. La Med. Biol. 1996/4; 27-31.
• Pharm DQ, Pham AQ. Interction potential between cranberry juice and warfarin. Am J Health Syst Pharm 2007; 64:490-4.
• Pradhan A. Majumdar M.K. Metabolismo f some drugs by intestinal lactobacilli and their toxicological considerations. Acta Pharmacol Toxicol 1986; 58: 11-15.
• Raz R, et al. Clin Infect Dis. 2000 Jan; 30(1):152-6.
• Reid G., Bruce A.W., Taylor M. Vaginal flora and urinary tract infections. Current Opinion in Infectious Disease 1991; 4: 37-41.
• Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol. 1999;17:359-63.
• Reid G, Bruce AW, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30:49-52.
• Remer T, Manz F. Potential renal acid load of foods and its influence on urine ph. J Am Diet Assoc. 1995;95:791-797.
• Ronald AR. The Etiology of Urinary Tract Infection: Traditional and Emerging Pathogens uncomplicates urinary tract. DiseaseaMonth 2002; 49: 14S-19S.
• Sabir M., Bhide N. Study of some pharmacologic actions of berberine. Ind J Physiol Pharm 1971; 15: 111-132.
• Schindler G, Patzak U, Brinkhaus B, von Niecieck A, Wittig J, Krähmer N, Glöckl I, Veit M. Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol. 2002 Aug; 42(8):920-7.
• Scholes D, et al. J Infect Dis, 2000 Oct; 182:1177-82, Raz R, et al. Clin Infect Dis. 2000 Jan; 30(1):152-6.
• Scott J. On the biochemical similarities of ascorbic acid and interferon. J Theor Biol 1982; 98: 235-238
• Serraino I. Et al. Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci. 73(9):1097-114, 2003.
• Shahani K.M., Ayebo A.D. Role of dietary lactobacilli in gastrointestinal microecology. Am J Clin Nutr 1980; 33: 2448-2457.
• Shipochiliev T, Farmadjiev G. Spectrum of the antiinflammatory effect of Arctostaphylos uva ursi and Achillea millefolium L. Probl Vutr Med 1984; 12: 99-107.
• Sobel JD, Kaye D. Urinary Tract Infections. In Mandell, Doublas, and Bennett’s Principles and Practice of Infectious Diseases, ed.s Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone, 2000:773-805., Johnson CC. Defi nitions, classifi cation, and clinical presentation of urinary tract infections. Med Clin North Am 1991;75(2):241-252.
• Sobel JD, Kaye D. Urinary Tract Infections. In Mandell, Doublas, and Bennett’s Principles and Practice of Infectious Diseases, ed.s Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone, 2000:773-805.
• Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984;131:1013-6.
• Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001;183(1):S1-S4.
• Stamm WE, at al. N Engl J Med. 1993; 329:1328-34.
• Stapleton AE, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus prebiotico given intravaginally for prevention of recurrent urinary tract infection. Curr Microbiol. 2011; 63:484-90.
• Stothers, L.: A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic Cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002 Jun;9(3):1558-62.
• Sun D., Courtney H.S., Beachey E.R., Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrobial Agents and Chemiotherapy 1988; 32: 1370-1374.
• Tomomatsu H., Health effects of oligosaccharides. Food Tech 1994; October: 61-65.
• Vesely R., Negri R., Bianchi-Salvadori B. et al. Influence of a diet addition with yogurt on the mouse immune system. EOS J Immunol Immunopharmacol 1985; 5: 30-35.
• Vogel V.J. American Indian Medicine. Norman OK: University of Oklahoma Press. 1970: p 356-357.
• Walker E et al - Cranberry juice concentrate: UTI prophilaxis - J Fam Pract 1997; 45: 167-8.
• Warren JW. The catheter and urinary tract infection. Med Clin North Am 1991;75(2):481-493.
• Wechsler A. Recurrent cystitis in non-pregnant women. Clin Evid 2003.
• Welch AA, Mulligan A, Bingham SA, Khaw KT, Urine pH is an indicator of dietary acid-base load, fruit and vegetables and meat intakes: results from the European Prospective Investigation into Cancer and Nutrition Norfolk population study. Br J Nutr. 2008;99(6):1335-43.
• Wildfeuer A., Meyerhofer D. Study of the influence of phytopreparation on the cellular function of bodily defense. Arzneim Forsch 1994; 44: 361-366.
• Wilson T, Porcari JP, Harbin D. Cranberry extract inhinbits low density lipoprotein oxidation. Life sci 1998;62; PL 381 -6.
• Yarnell E. - Botanical medicine for cystitis. Alternative and complementary therapies - 1997 : 269-75.
• Youngken HW. - Textbook of pharmacognosy, 6th ed. Philadelphia, PA, Blakiston, 1950.
• Zafriri D et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989;33(1):92-98.
• Zhanel GG, Harding GK, Guay DR. Asymptomatic bacteriuria. Which patients should be treated. Arch Intern Med 1990;150(7):1389-1396.